molecular function |
| GO:0051400 | | BH domain binding | | Interacting selectively and non-covalently with the Bcl-2 homology (BH) domain of a protein. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains. |
| GO:0051087 | | chaperone binding | | Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. |
| GO:0031072 | | heat shock protein binding | | Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock. |
| GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| GO:0044325 | | ion channel binding | | Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
| GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0046982 | | protein heterodimerization activity | | Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. |
| GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
biological process |
| GO:0001783 | | B cell apoptotic process | | Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
| GO:0001782 | | B cell homeostasis | | The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
| GO:0002352 | | B cell negative selection | | Any process leading to negative selection in B cells. Mechanisms of negative selection include anergy and deletion. |
| GO:0097202 | | activation of cysteine-type endopeptidase activity | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase. |
| GO:0006919 | | activation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| GO:0008635 | | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c. |
| GO:0006987 | | activation of signaling protein activity involved in unfolded protein response | | The conversion of a specific protein, possessing protein kinase and endoribonuclease activities, to an active form as a result of signaling via the unfolded protein response. |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0031100 | | animal organ regeneration | | The regrowth of a lost or destroyed animal organ. |
| GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| GO:1902262 | | apoptotic process involved in blood vessel morphogenesis | | Any apoptotic process that is involved in blood vessel morphogenesis. |
| GO:0097190 | | apoptotic signaling pathway | | A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
| GO:0001974 | | blood vessel remodeling | | The reorganization or renovation of existing blood vessels. |
| GO:0007420 | | brain development | | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
| GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| GO:0034644 | | cellular response to UV | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
| GO:0071260 | | cellular response to mechanical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| GO:0019835 | | cytolysis | | The rupture of cell membranes and the loss of cytoplasm. |
| GO:0031018 | | endocrine pancreas development | | The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin. |
| GO:0032469 | | endoplasmic reticulum calcium ion homeostasis | | Any process involved in the maintenance of an internal steady state of calcium ions within the endoplasmic reticulum of a cell or between the endoplasmic reticulum and its surroundings. |
| GO:0010248 | | establishment or maintenance of transmembrane electrochemical gradient | | The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore. |
| GO:0097192 | | extrinsic apoptotic signaling pathway in absence of ligand | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. |
| GO:0044346 | | fibroblast apoptotic process | | Any apoptotic process in a fibroblast, a connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. |
| GO:0048872 | | homeostasis of number of cells | | Any biological process involved in the maintenance of the steady-state number of cells within a population of cells. |
| GO:0008630 | | intrinsic apoptotic signaling pathway in response to DNA damage | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered. |
| GO:0070059 | | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. |
| GO:0001776 | | leukocyte homeostasis | | The process of regulating the proliferation and elimination of cells of the immune system such that the total number of cells of a particular cell type within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
| GO:0035108 | | limb morphogenesis | | The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping. |
| GO:0008053 | | mitochondrial fusion | | Merging of two or more mitochondria within a cell to form a single compartment. |
| GO:0002262 | | myeloid cell homeostasis | | The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
| GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| GO:0032471 | | negative regulation of endoplasmic reticulum calcium ion concentration | | Any process that decreases the concentration of calcium ions in the endoplasmic reticulum. |
| GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0033137 | | negative regulation of peptidyl-serine phosphorylation | | Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:1903896 | | positive regulation of IRE1-mediated unfolded protein response | | Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0010524 | | positive regulation of calcium ion transport into cytosol | | Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components. |
| GO:1900103 | | positive regulation of endoplasmic reticulum unfolded protein response | | Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response. |
| GO:1901030 | | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
| GO:0045862 | | positive regulation of proteolysis | | Any process that activates or increases the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein. |
| GO:0090200 | | positive regulation of release of cytochrome c from mitochondria | | Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
| GO:0048597 | | post-embryonic camera-type eye morphogenesis | | The process in which the anatomical structures of the eye are generated and organized during post-embryonic development. |
| GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| GO:0051726 | | regulation of cell cycle | | Any process that modulates the rate or extent of progression through the cell cycle. |
| GO:0046902 | | regulation of mitochondrial membrane permeability | | Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane. |
| GO:0051881 | | regulation of mitochondrial membrane potential | | Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
| GO:0043497 | | regulation of protein heterodimerization activity | | Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer. |
| GO:0043496 | | regulation of protein homodimerization activity | | Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer. |
| GO:0001836 | | release of cytochrome c from mitochondria | | The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation. |
| GO:0010225 | | response to UV-C | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-C radiation stimulus. UV-C radiation (UV-C light) spans the wavelengths 100 to 280 nm. |
| GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| GO:0045471 | | response to ethanol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| GO:0009620 | | response to fungus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a fungus. |
| GO:0010332 | | response to gamma radiation | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. |
| GO:0042542 | | response to hydrogen peroxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| GO:0010046 | | response to mycotoxin | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mycotoxin stimulus. A mycotoxin is a toxic chemical substance produced by fungi. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0070242 | | thymocyte apoptotic process | | Any apoptotic process in a thymocyte, an immature T cell located in the thymus. |
| GO:0060068 | | vagina development | | The reproductive developmental process whose specific outcome is the progression of the vagina over time, from its formation to the mature structure. |
cellular component |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| GO:0031307 | | integral component of mitochondrial outer membrane | | The component of the mitochondrial outer membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0031966 | | mitochondrial membrane | | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
| GO:0005741 | | mitochondrial outer membrane | | The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. |
| GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| GO:0046930 | | pore complex | | Any small opening in a membrane that allows the passage of gases and/or liquids. |